Geron Corporation (GERN)

Nasdaq: GERN · Pharmaceutical Preparations · Foster City, CA · filing with the SEC since 1996

Grade3.5

◀ Past 4.3● Present 3.5▶ Future 3.1

Overview Business Financials Grade Forecast Sentiment Ownership People Filings Patents Chart

Income statement, as filed

In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.

Income statement, by fiscal year, newest first
Fiscal year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Report filed	Mar 2, 2026	Feb 27, 2025	Feb 28, 2024	Mar 16, 2023	Mar 10, 2022	Mar 11, 2021	Mar 12, 2020	Mar 7, 2019	Mar 16, 2018	Mar 1, 2017
Revenue	·	·	237,000	596,000	1,393,000	253,000	460,000	1,066,000	1,065,000	6,162,000
Research and development	71,433,000	103,738,000	125,046,000	95,518,000	85,727,000	51,488,000	52,072,000	13,432,000	11,033,000	18,047,000
Selling, general and administrative	159,256,000	145,732,000	69,135,000	43,628,000	·	·	·	·	·	·
General and administrative	·	·	69,135,000	43,628,000	29,665,000	25,678,000	20,893,000	18,707,000	19,287,000	18,761,000
Total operating expenses	252,466,000	250,726,000	194,181,000	139,146,000	115,392,000	77,166,000	72,965,000	32,139,000	30,320,000	36,808,000
Total costs and expenses	4,745,000	1,256,000	0	·	·	·	·	·	·	·
Operating income	-68,585,000	-173,732,000	-193,944,000	-138,550,000	-113,999,000	-76,913,000	-72,505,000	-31,073,000	-29,255,000	-30,646,000
Interest expense	32,657,000	18,504,000	8,312,000	6,882,000	3,740,000	760,000	·	·	·	·
Interest and investment income	18,117,000	19,607,000	18,152,000	2,529,000	527,000	1,828,000	4,221,000	3,251,000	·	·
Other income (expense), net	-375,000	-236,000	-23,000	1,002,000	1,100,000	168,000	-69,000	-114,000	·	·
Income before income taxes	-83,425,000	-174,522,000^r	-181,734,000	-141,902,000	·	·	·	·	·	·
Income tax expense	75,000	449,000	22,000	·	·	·	·	·	·	·
Net income including non-controlling interests	·	-174,572,000	-184,127,000	-141,901,000	-116,112,000	-75,617,000	-68,548,000	-27,017,000	-27,916,000	-29,537,000
Net income	-83,500,000	-174,572,000	-184,127,000	-141,901,000	-116,112,000	-75,617,000	-68,548,000	-27,017,000	-27,916,000	-29,537,000
Earnings per share, basic	-0.13	-0.27	-0.32	-0.37	-0.35	-0.28	·	·	-0.18	-0.19
Earnings per share, diluted	-0.13	-0.27	-0.32	-0.37	-0.35	-0.28	·	·	-0.18	-0.19
Earnings per share, basic and diluted	·	·	·	·	-0.35	-0.28	-0.36	-0.15	-0.18	-0.19
Weighted average shares, basic	666,662,989	646,033,247	570,645,405	380,784,846	327,631,814	271,460,265	·	·	159,224,986	159,045,644
Weighted average shares, diluted	666,662,989	646,033,247	570,645,405	380,784,846	327,631,814	271,460,265	·	·	159,224,986	159,045,644
Weighted average shares, basic and diluted	·	·	·	·	327,631,814	271,460,265	190,160,311	176,504,996	159,224,986	159,045,644

As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. ^r restated by the company in a later report; ^b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.

What each line is, and the XBRL concept behind it

Revenue what customers paid for what it sold

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:Revenues

Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost

Selling, general and administrative the cost of selling and of running the companyus-gaap:SellingGeneralAndAdministrativeExpense

General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense

Total operating expenses the running costs togetherus-gaap:OperatingExpenses

Total costs and expenses every operating cost, the cost of revenue includedus-gaap:OperatingCostsAndExpenses

Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss

Interest expense what its borrowing cost

us-gaap:InterestExpenseNonoperating
us-gaap:InterestExpense

Interest and investment income what its cash and investments earnedus-gaap:InvestmentIncomeInterest

Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense

Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit

Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss

Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss

Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic

Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted

Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted

Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic

Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted

SI Assistanton GERN · research, not advice